SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-016366
Filing Date
2024-05-14
Accepted
2024-05-14 08:13:07
Documents
49
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rvph20240331_10q.htm   iXBRL 10-Q 726143
2 EXHIBIT 31.1 ex_670004.htm EX-31.1 11068
3 EXHIBIT 31.2 ex_670005.htm EX-31.2 11214
4 EXHIBIT 32.1 ex_670006.htm EX-32.1 9078
  Complete submission text file 0001437749-24-016366.txt   3726519

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rvph-20240331.xsd EX-101.SCH 36171
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20240331_def.xml EX-101.DEF 225136
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20240331_lab.xml EX-101.LAB 209100
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20240331_pre.xml EX-101.PRE 248746
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rvph-20240331_cal.xml EX-101.CAL 20919
53 EXTRACTED XBRL INSTANCE DOCUMENT rvph20240331_10q_htm.xml XML 517735
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38634 | Film No.: 24941538
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)